Mylin A. Torres, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast Cancer (NCT04690855) | Mylin A. Torres, MD | 2021-10-04 |
Track Mylin A. Torres, MD automatically
Every clearance here is in the API, with alerts when new ones post.